Fluorine-18-labeled tropane analogs for PET imaging studies of the doramine transporter

Synapse

Volumn 37, Issue 2, 2000, Pages 109-117

  Mach, Robert H ^a   Nader, Michael A ^a   Ehrenkaufer, Richard L ^a   Gage, H Donald ^a   Childers, Steven R ^a   Hodges, L Mark ^b   Hodges, Melinda M ^b   Davies, Huw M L ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Dopaminergic terminal; Dopemine transporter; PET

Indexed keywords

COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; FLUORINE 18; TRACER; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BINDING AFFINITY; CELL LABELING; CEREBELLUM; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; LIGAND BINDING; MONKEY; NEUROCHEMISTRY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ACTIVITY RELATION; TRANSGENIC MOUSE;

ANIMALS; BASAL GANGLIA; BLOOD; BRAIN; CARRIER PROTEINS; CEREBELLUM; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FLUORINE RADIOISOTOPES; INJECTIONS, INTRAVENOUS; KINETICS; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, EMISSION-COMPUTED; TROPANES;

EID: 0033938814     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(200008)37:2<109::AID-SYN5>3.0.CO;2-3     Document Type: Article

References (41)

1. 11C-nomifensine and positron emission tomography. Acta Neurol Scand 78:283-287.
2. 125I]RTI-55: a potent ligand for dopamine transporters. Eur J Pharmacol 194:133-134.
3. Carroll FI, Lewin AH, Boja JW, Kuhar MJ. 1992. Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J Med Chem 35: 969-981.
4. Carroll FI, Howell LL, Kuhar MJ. 1999. Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42:2721-2736.
5. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-4002.
6. 18F]GBR 13119 binding autoradiography in rat brain. J Neurochem 55:619-623.
7. Davies HML, Saikali S, Sexton T, Childers SR. 1993. Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum. Eur J Pharmacol 244:93-97.
8. Davies HML, Saikali E, Huby NJS, Gilliatt VJ, Matasi JJ, Sexton T, Childers SR. 1994. Synthesis of 2β-acyl-3β-aryl-8-azabicyclo[3.2.1]-octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J Med Chem 37:1262-1268.
9. 11C]dl'threo-methylphenidate for the presynaptic dopaminergic neuron. Synapse 18:152-160.
10. Dischino DD, Welch MJ, Kilbourn MJ, Raichle ME. 1983. Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J Nucl Med 24:1030-1038.
11. Dutta AK, Xu C, Reith MEA. 1996. Structure-activity relationship study of novel 4-[2-[bis(4-fluorophenyl)methoxy]ethyl]-1-[3-phenylpropyl)piperidine analogs: synthesis and biological evaluation at the dopamine and serotonin transporter sites. J Med Chem 39:749-756.
12. Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elamleh DR, Callahan RJ, Barrow SA, Graham W, Meltzer PC, Hanson RN, Madras BK. 1998. Rapid detection of Parkinson's disease by SPECT with altopane: a selective ligand for dopamine transporters. Synapse 29:128-141.
13. 18F]N-methylspiroperidol in baboon using PET. Nucl Med Biol 13:281-284.
14. 11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine. Eur J Pharmacol 281:141-149.
15. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
16. Goodman MM, Keil R, Shoup TM, Eshima D, Eshima L, Kilts C, Votaw J, Camp VM, Votaw D, Smith E, Kung MP, Malveaux E. 1997. Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters. J Nucl Med 38:119-125.
17. Innis R, Seibyl JP, Scanley BE, Laurelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zogbi S, Wang S, Gao Y, Neumeyer JL. 1993. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Natl Acad Sci USA 90:11965-11969.
18. 18F]GBR 13119. Imaging the dopamine uptake system in vivo. Nucl Med Biol 16:569-576.
19. Kung M-P, Essman WD, Frederick D, Meegalla S, Goodman M, Mu M, Lucki I, Kung HF. 1995. IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse 20:316-324.
20. 18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: characterization in human subjects. Synapse 28:244-250.
21. Lassen NA. 1992. Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. J Cereb Blood Flow Metab 12:709-716.
22. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747.
23. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995-1010.
24. 11C]β-CIT-FP for quantitation of the dopamine transporter. Nucl Med Biol 24:621-627.
25. 2 receptor-based imaging agents. Nucl Med Biol 20:777-794.
26. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol Pharmacol 36:518-524.
27. 99mtechnetium probe to label the dopamine transporter in brain by SPECT imaging. Synapse 22:239-246.
28. Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY, Stopa EG, Babich J, Fischman AJ. 1998. Altopane, a SPECT or PET imaging probe for dopamine neurons. III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain. Synapse 29:116-127.
29. 99mTc complex as a dopamine transporter imaging agent. J Am Chem Soc 117:11037-11038.
30. Meltzer PC, Blundell P, Jones AG, Mahmood A, Garada B, Zimmerman RE, Davison A, Holman BL, Madras BK. 1997. A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain. J Med Chem 40:1835-1844.
31. 11C-CFT. Synapse 24:262-272.
32. Pan D, Gatley SJ, Dewey SL, Chen R, Alexoff DA, Ding Y-S, Fowler J. 1994. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Eur J Pharmacol 264:177-182.
33. 11C]β-CFT in early Parkinson's disease. Synapse 21:97-103.
34. 18F]β-CFT, is reduced in early Parkinson's disease. Synapse 31:119-124.
35. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. 1998. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1:132-137.
36. Tatsumi M, Groshan K, Blakely RD, Richelson E. 1997. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
37. Volkow ND, Ding Y-S, Fowler JS, Wang G-J, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, Wolf AP. 1995. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456-463.
38. Volkow ND, Wang G-J, Fowler JS, Gatley SJ, Ding Y-S, Logan J, Dewey SL, Hitzemann R, Lieberman J. 1996. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci USA 93:10388-10392.
39. Volkow ND, Wang G-J, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE. 1997. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830.
40. 18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. Nucl Med Biol 23:141-146.
41. 11C]WIN 35,428. Synapse 15:130-142.